{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:54:25Z","timestamp":1778943265477,"version":"3.51.4"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bcp.2020.114173","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T22:09:19Z","timestamp":1595628559000},"page":"114173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease"],"prefix":"10.1016","volume":"180","author":[{"given":"Roni F.","family":"Kunst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marije","family":"Niemeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc J.W.","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"Spee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stan F.J.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114173_b0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(00)80421-3","article-title":"Chronic cholestatic diseases","volume":"32","author":"Poupon","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2020.114173_b0010","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b0015","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bcp.2020.114173_b0020","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/ten.tec.2016.0187","article-title":"Hepatocyte isolation after laparoscopic liver resection","volume":"22","author":"Horner","year":"2016","journal-title":"Tissue Eng. Part C Methods"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/pr.2017.284","article-title":"Human hepatocyte transplantation for liver disease: current status and future perspectives","volume":"83","author":"Iansante","year":"2018","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0030","first-page":"771","article-title":"Isolation, culture, and transplantation of human hepatocytes","volume":"68","author":"Strom","year":"1982","journal-title":"J. Natl Cancer Inst."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0040","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/DMR-100100564","article-title":"Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction","volume":"32","author":"Hengstler","year":"2000","journal-title":"Drug Metab. Rev."},{"issue":"6438","key":"10.1016\/j.bcp.2020.114173_b0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.aau7307","article-title":"Long-term functional maintenance of primary human hepatocytes in vitro","volume":"364","author":"Xiang","year":"2019","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.bcp.2020.114173_b0050","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1517\/17425255.2014.967680","article-title":"Competency of different cell models to predict human hepatotoxic drugs","volume":"10","author":"G\u00f3mez-Lech\u00f3n","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/toxsci\/kfg064","article-title":"Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems","volume":"73","author":"Boess","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/dmd.109.028407","article-title":"An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes","volume":"38","author":"Ansede","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114173_b0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","article-title":"Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes","volume":"34","author":"Oorts","year":"2016","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2020.114173_b0085","doi-asserted-by":"crossref","unstructured":"Swift*, B., N.D. Pfeifer*, and K.L. Brouwer, Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug metabolism reviews, 2010. 42(3): p. 446-471.","DOI":"10.3109\/03602530903491881"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2020.114173_b0095","doi-asserted-by":"crossref","unstructured":"Wanninger, J., M. Neumeier, C. Hellerbrand, D. Schacherer, S. Bauer, T.S. Weiss, et al., Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2011. 1811(10): p. 626-633.","DOI":"10.1016\/j.bbalip.2010.11.001"},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b0100","first-page":"675","article-title":"Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation","volume":"3","author":"Kirovski","year":"2010","journal-title":"Int. J. Clin. Exp. Path."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0105","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/cr.2009.73","article-title":"Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells","volume":"19","author":"Wobser","year":"2009","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2020.114173_b0110","doi-asserted-by":"crossref","first-page":"28178","DOI":"10.1038\/srep28178","article-title":"Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes","volume":"6","author":"Davidson","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jhep.2018.09.007","article-title":"Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells","volume":"70","author":"Kim","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41422-018-0103-x","article-title":"Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens","volume":"29","author":"Fu","year":"2019","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0125","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.stem.2018.10.018","article-title":"Sun, et al., In vitro expansion of primary human hepatocytes with efficient liver repopulation capacity","volume":"23","author":"Zhang","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bcp.2020.114173_b0130","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0135","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/j.gastro.2013.09.009","article-title":"Mice with human livers","volume":"145","author":"Grompe","year":"2013","journal-title":"Gastroenterology"},{"issue":"5150","key":"10.1016\/j.bcp.2020.114173_b0140","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.8108734","article-title":"Replacement of diseased mouse liver by hepatic cell transplantation","volume":"263","author":"Rhim","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bcp.2020.114173_b0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/978-1-60761-688-7_27","article-title":"Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity","volume":"640","author":"Strom","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/17425255.2.2.183","article-title":"Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies","volume":"2","author":"Castell","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0155","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.20372","article-title":"Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells","volume":"40","author":"Yokoo","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2020.114173_b0170","doi-asserted-by":"crossref","unstructured":"M.-J. Marion O. Hantz D. Durantel The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies Hepatocytes 2010 Springer 261 272.","DOI":"10.1007\/978-1-60761-688-7_13"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/bcpt.12631","article-title":"Human Hepatic Hepa RG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP 450 Activity\/Metabolism and Significantly Outperform Standard HepG2\/C3A Cells for Pharmaceutical and Therapeutic Applications","volume":"120","author":"Nelson","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b0180","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0185","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/toxsci\/kfv136","article-title":"Comparative proteomic characterization of 4 human liver-derived single cell culture models reveals significant variation in the capacity for drug disposition, bioactivation, and detoxication","volume":"147","author":"Sison-Young","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0190","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Anth\u00e9rieu","year":"2013","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0195","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/toxsci\/kfy101","article-title":"Effect of the catechol-O-methyltransferase inhibitors tolcapone and entacapone on fatty acid metabolism in HepaRG cells","volume":"164","author":"Gr\u00fcnig","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2020.114173_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113860","article-title":"Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms","author":"Gr\u00fcnig","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0205","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1083\/jcb.123.6.1761","article-title":"WIF-B cells: an in vitro model for studies of hepatocyte polarity","volume":"123","author":"Ihrke","year":"1993","journal-title":"The Journal of Cell Biology"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2020.114173_b0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tox.2004.02.009","article-title":"Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents","volume":"198","author":"Mersch-Sundermann","year":"2004","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160525","article-title":"M. de la Mata, et al., AP-1 inhibition by SR 11302 protects human Hepatoma HepG2 cells from bile acid-induced Cytotoxicity by restoring the NOS-3 expression","volume":"11","author":"Gonzalez-Rubio","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2020.114173_b0220","series-title":"Protocols in In Vitro Hepatocyte Research","first-page":"363","article-title":"Critical factors in the assessment of cholestatic liver injury in vitro","author":"Woolbright","year":"2015"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0225","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2012.07.029","article-title":"Tauro-\u03b2-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential","volume":"424","author":"Denk","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0230","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","article-title":"Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes","volume":"24","author":"Ricchi","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2020.114173_b0235","series-title":"Protocols in In Vitro Hepatocyte Research","first-page":"53","article-title":"Immortalized human hepatic cell lines for in vitro testing and research purposes","author":"Ramboer","year":"2015"},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0240","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/labinvest.3700590","article-title":"Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes","volume":"87","author":"De Gottardi","year":"2007","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/hep.25967","article-title":"Glycogen synthase kinase 3-mediated voltage-dependent anion channel phosphorylation controls outer mitochondrial membrane permeability during lipid accumulation","volume":"57","author":"Martel","year":"2013","journal-title":"Hepatology"},{"issue":"6 Pt 1","key":"10.1016\/j.bcp.2020.114173_b0250","first-page":"G1060","article-title":"Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines","volume":"266","author":"Grubman","year":"1994","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0255","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12015-019-09935-x","article-title":"Advances in pluripotent stem cells: history, mechanisms, technologies, and applications","volume":"16","author":"Liu","year":"2020","journal-title":"Stem cell reviews and reports"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0265","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nprot.2012.153","article-title":"Production of hepatocyte-like cells from human pluripotent stem cells","volume":"8","author":"Hannan","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2020.114173_b0270","series-title":"Pluripotent Stem Cells","first-page":"141","article-title":"Directed differentiation of pluripotent stem cells to functional hepatocytes","author":"Roelandt","year":"2013"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2010.06.014","article-title":"Directed differentiation of murine-induced pluripotent stem cells to functional hepatocyte-like cells","volume":"54","author":"Sancho-Bru","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0280","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly efficient generation of human hepatocyte\u2013like cells from induced pluripotent stem cells","volume":"51","author":"Si-Tayeb","year":"2010","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.bcp.2020.114173_b0285","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/cr.2009.107","article-title":"Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells","volume":"19","author":"Song","year":"2009","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0290","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12072-011-9251-5","article-title":"Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines","volume":"5","author":"Takata","year":"2011","journal-title":"Hep. Intl."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0295","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/emmm.201000085","article-title":"Regulation of liver regeneration by growth factors and cytokines","volume":"2","author":"B\u00f6hm","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2020.114173_b0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.diff.2018.03.002","article-title":"Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules","volume":"101","author":"Asumda","year":"2018","journal-title":"Differentiation"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0305","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13287-018-0794-4","article-title":"Highly efficient and expedited hepatic differentiation from human pluripotent stem cells by pure small-molecule cocktails","volume":"9","author":"Du","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0310","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.stemcr.2015.04.001","article-title":"Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells","volume":"4","author":"Siller","year":"2015","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15058-6","article-title":"Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines","volume":"11","author":"Boon","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0320","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/mt.2010.241","article-title":"Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX","volume":"19","author":"Inamura","year":"2011","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0325","first-page":"200","article-title":"Directed differentiation of pluripotent stem cells by transcription factors","volume":"42","author":"Oh","year":"2019","journal-title":"Mol. Cells"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/mt.2011.234","article-title":"Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4\u03b1 transduction","volume":"20","author":"Takayama","year":"2012","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2020.114173_b0335","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jcb.25494","article-title":"Transcription factors and medium suitable for initiating the differentiation of human-induced pluripotent stem cells to the hepatocyte lineage","volume":"117","author":"Tomizawa","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0340","article-title":"Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture","volume":"9","author":"Gieseck","year":"2014","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.bcp.2020.114173_b0345","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.celrep.2017.11.005","article-title":"Massive and reproducible production of liver buds entirely from human pluripotent stem cells","volume":"21","author":"Takebe","year":"2017","journal-title":"Cell reports"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0350","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nprot.2014.020","article-title":"Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant","volume":"9","author":"Takebe","year":"2014","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b0355","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1002\/bit.26970","article-title":"Optimized protocol for the hepatic differentiation of induced pluripotent stem cells in a fluidic microenvironment","volume":"116","author":"Danoy","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bcp.2020.114173_b0360","doi-asserted-by":"crossref","unstructured":"M. Parafati R.J. Kirby S. Khorasanizadeh F. Rastinejad S. Malany A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis Disease models & mechanisms 11 9 2018 p. dmm033530.","DOI":"10.1242\/dmm.033530"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0365","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0370","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/stem.3154","article-title":"Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases","volume":"38","author":"Maepa","year":"2020","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0375","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.27165","article-title":"Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells","volume":"60","author":"Dianat","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0380","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nbt.3294","article-title":"Directed differentiation of cholangiocytes from human pluripotent stem cells","volume":"33","author":"Ogawa","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0385","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.4360","article-title":"Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids","volume":"23","author":"Sampaziotis","year":"2017","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0390","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt.3275","article-title":"Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation","volume":"33","author":"Sampaziotis","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2020.114173_b0395","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-physiol-021113-170255","article-title":"Cellular homeostasis and repair in the mammalian liver","volume":"77","author":"Stanger","year":"2015","journal-title":"Annu. Rev. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0400","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cell.2015.07.026","article-title":"Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer","volume":"162","author":"Font-Burgada","year":"2015","journal-title":"Cell"},{"issue":"7564","key":"10.1016\/j.bcp.2020.114173_b0405","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature14863","article-title":"Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver","volume":"524","author":"Wang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114173_b0410","article-title":"A Human Liver Cell Atlas: Revealing Cell Type Heterogeneity and Adult Liver Progenitors by Single-Cell RNA-sequencing","author":"Aizarani","year":"2019","journal-title":"bioRxiv"},{"issue":"11","key":"10.1016\/j.bcp.2020.114173_b0415","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/s41556-019-0402-6","article-title":"Epigenetic remodelling licences adult cholangiocytes for organoid formation and liver regeneration","volume":"21","author":"Aloia","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2020.114173_b0420","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bcp.2020.114173_b0425","doi-asserted-by":"crossref","first-page":"174557","DOI":"10.1242\/dev.174557","article-title":"Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool","volume":"146","author":"Prior","year":"2019","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0430","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","article-title":"Long-term expansion of functional mouse and human hepatocytes as 3D organoids","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2020.114173_b0435","doi-asserted-by":"crossref","unstructured":"W.C. Peng C.Y. Logan M. Fish T. Anbarchian F. Aguisanda A. \u00c1lvarez-Varela et al. Inflammatory cytokine TNF\u03b1 promotes the long-term expansion of primary hepatocytes in 3D culture Cell 175 6 2018 pp. 1607\u20131619. e15.","DOI":"10.1016\/j.cell.2018.11.012"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0440","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.stemcr.2017.02.015","article-title":"Long-term adult feline liver organoid cultures for disease modeling of hepatic steatosis","volume":"8","author":"Kruitwagen","year":"2017","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bcp.2020.114173_b0445","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","article-title":"\u03b11-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0450","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12072-019-10007-y","article-title":"Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease","volume":"14","author":"G\u00f3mez-Mariano","year":"2020","journal-title":"Hep. Intl."},{"issue":"12","key":"10.1016\/j.bcp.2020.114173_b0455","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer\u2013derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0460","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-020-1555-8","article-title":"Different approaches for transformation of mesenchymal stem cells into hepatocyte-like cells","volume":"11","author":"Afshari","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0465","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3892\/mmr.2014.2935","article-title":"Adipose tissue-derived mesenchymal stem cells differentiated into hepatocyte-like cells in vivo and in vitro","volume":"11","author":"Yin","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2020.114173_b0470","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.procbio.2010.06.009","article-title":"In vitro hepatic differentiation of umbilical cord-derived mesenchymal stem cell","volume":"45","author":"Yoon","year":"2010","journal-title":"Process Biochem."},{"issue":"s1","key":"10.1016\/j.bcp.2020.114173_b0475","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3233\/BME-141249","article-title":"Differentiation of human umbilical cord-derived mesenchymal stem cells into hepatocytes in vitro","volume":"25","author":"Zheng","year":"2015","journal-title":"Bio-Med. Mater. Eng."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0485","first-page":"2009","article-title":"Differentiation of umbilical cord mesenchymal stem cells into hepatocytes in comparison with bone marrow mesenchymal stem cells","volume":"18","author":"Yu","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0490","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0963689718780332","article-title":"Functional 3D human liver bud assembled from MSC-derived multiple liver cell lineages","volume":"28","author":"Li","year":"2019","journal-title":"Cell Transplant."},{"key":"10.1016\/j.bcp.2020.114173_b0495","article-title":"Regional differences in human biliary tissues and corresponding in vitro derived organoids","author":"Rimland","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0500","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.30470","article-title":"Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile","volume":"70","author":"Soroka","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrm.2016.24","article-title":"Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style","volume":"17","author":"Merrell","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-22596-z","article-title":"Transdifferentiation of pancreatic progenitor cells to hepatocyte-like cells is not serum-dependent when facilitated by extracellular matrix proteins","volume":"8","author":"Gratte","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0515","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.stem.2014.01.003","article-title":"Direct reprogramming of human fibroblasts to functional and expandable hepatocytes","volume":"14","author":"Huang","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100134","article-title":"Direct reprogramming of human fibroblasts to hepatocyte-like cells by synthetic modified mRNAs","volume":"9","author":"Simeonov","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0525","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1053\/j.gastro.2018.01.066","article-title":"Biotechnology challenges to in vitro maturation of hepatic stem cells","volume":"154","author":"Chen","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0530","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12072-013-9432-5","article-title":"Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors","volume":"7","author":"Kogiso","year":"2013","journal-title":"Hep. Intl."},{"key":"10.1016\/j.bcp.2020.114173_b0535","doi-asserted-by":"crossref","first-page":"38694","DOI":"10.1038\/srep38694","article-title":"Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: a novel in vitro cholestatic model","volume":"6","author":"Ni","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0540","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","article-title":"Non-alcoholic fatty liver disease (NAFLD) models in drug discovery","volume":"13","author":"Cole","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0545","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.dmpk.2017.11.006","article-title":"Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator","volume":"33","author":"Kanamori","year":"2018","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0550","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.dmpk.2017.11.003","article-title":"Organ\/body-on-a-chip based on microfluidic technology for drug discovery","volume":"33","author":"Kimura","year":"2018","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41578-018-0034-7","article-title":"Advances in organ-on-a-chip engineering","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Rev. Mater."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0560","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00204-019-02427-4","article-title":"Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid","volume":"93","author":"Foster","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"517","key":"10.1016\/j.bcp.2020.114173_b0565","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax5516","article-title":"Reproducing human and cross-species drug toxicities using a Liver-Chip","volume":"11","author":"Jang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2020.114173_b0570","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31106","article-title":"Liver-on-a-Chip Models of Fatty Liver Disease","author":"Hassan","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2020.114173_b0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2019.04.019","article-title":"Development and validation of bioengineered intestinal tubules for translational research aimed at safety and efficacy testing of drugs and nutrients","volume":"60","author":"Jochems","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.bcp.2020.114173_b0580","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2016.07.009","article-title":"Upscaling of a living membrane for bioartificial kidney device","volume":"790","author":"Chevtchik","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114173_b0585","doi-asserted-by":"crossref","first-page":"16702","DOI":"10.1038\/srep16702","article-title":"Human proximal tubule epithelial cells cultured on hollow fibers: living membranes that actively transport organic cations","volume":"5","author":"Jansen","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0590","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1039\/C7BM00963A","article-title":"Three-dimensional multiscale fiber matrices: development and characterization for increased HepG2 functional maintenance for bio-artificial liver application","volume":"6","author":"Verma","year":"2018","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0595","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/aa70c7","article-title":"3D liver membrane system by co-culturing human hepatocytes, sinusoidal endothelial and stellate cells","volume":"9","author":"Ahmed","year":"2017","journal-title":"Biofabrication"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0600","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/aac8fd","article-title":"Bioengineered bile ducts recapitulate key cholangiocyte functions","volume":"10","author":"Chen","year":"2018","journal-title":"Biofabrication"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0605","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.24760","article-title":"Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing","volume":"55","author":"Tostoes","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2020.114173_b0610","doi-asserted-by":"crossref","first-page":"35434","DOI":"10.1038\/srep35434","article-title":"Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability","volume":"6","author":"Hendriks","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32722-6","article-title":"Human hepatic 3D spheroids as a model for steatosis and insulin resistance","volume":"8","author":"Kozyra","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114173_b0620","unstructured":"Warburg, O., Versuche an \u00fcberlebendem karzinomgewebe. 1923: Biochem Z. . p. 317-333."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0625","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0003-2697(80)90284-5","article-title":"A new instrument for the rapid preparation of tissue slices","volume":"104","author":"Krumdieck","year":"1980","journal-title":"Anal. Biochem."},{"issue":"9","key":"10.1016\/j.bcp.2020.114173_b0630","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"De Graaf","year":"2010","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.bcp.2020.114173_b0635","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1007\/s00204-019-02611-6","article-title":"Transcriptomic characterization of culture-associated changes in murine and human precision-cut tissue slices","volume":"93","author":"Bigaeva","year":"2019","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0640","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12072-018-9913-7","article-title":"Precision-cut liver slices: a versatile tool to advance liver research","volume":"13","author":"Palma","year":"2019","journal-title":"Hep. Intl."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0645","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-016-1778-8","article-title":"Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach","volume":"91","author":"Vatakuti","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0650","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41587-019-0374-x","article-title":"An integrated perfusion machine preserves injured human livers for 1 week","volume":"38","author":"Eshmuminov","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"7703","key":"10.1016\/j.bcp.2020.114173_b0655","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41586-018-0047-9","article-title":"A randomized trial of normothermic preservation in liver transplantation","volume":"557","author":"Nasralla","year":"2018","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2020.114173_b0660","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/17474124.2018.1505499","article-title":"Normothermic ex-vivo liver perfusion: where do we stand and where to reach?","volume":"12","author":"Jayant","year":"2018","journal-title":"Expert review of gastroenterology & hepatology"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0665","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/tri.12576","article-title":"Normothermic liver preservation: a new paradigm?","volume":"28","author":"Ravikumar","year":"2015","journal-title":"Transpl. Int."},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0670","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/tri.13441","article-title":"The future of organ perfusion and re-conditioning","volume":"32","author":"Weissenbacher","year":"2019","journal-title":"Transpl. Int."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0675","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1056-8719(02)00184-3","article-title":"The isolated perfused liver: a new model using autologous blood and porcine slaughterhouse organs","volume":"46","author":"Grosse-Siestrup","year":"2001","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0680","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01926230290166841","article-title":"Isolated hemoperfused slaughterhouse livers as a valid model to study hepatotoxicity","volume":"30","author":"Grosse-Siestrup","year":"2002","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0685","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/TP.0b013e318223d817","article-title":"Hepatic steatosis and normothermic perfusion\u2014preliminary experiments in a porcine model","volume":"92","author":"Jamieson","year":"2011","journal-title":"Transplantation"},{"issue":"4\u20135","key":"10.1016\/j.bcp.2020.114173_b0690","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ymben.2009.05.005","article-title":"Metabolic preconditioning of donor organs: defatting fatty livers by normothermic perfusion ex vivo","volume":"11","author":"Nagrath","year":"2009","journal-title":"Metab. Eng."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0695","first-page":"1254","article-title":"Animal models of biliary injury and altered bile acid metabolism","volume":"1864","author":"Mariotti","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Disease"},{"key":"10.1016\/j.bcp.2020.114173_b0700","series-title":"Experimental Cholestasis Research","first-page":"249","article-title":"3, 5-Diethoxycarbonyl-1, 4-Dihydrocollidine Diet: A Rodent Model in Cholestasis Research","author":"Pose","year":"2019"},{"key":"10.1016\/j.bcp.2020.114173_b0705","doi-asserted-by":"crossref","unstructured":"Cai, S.-Y., M. Ge, A. Mennone, R. Hoque, X. Ouyang, and J.L. Boyer, Inflammasome is activated in the liver of cholestatic patients and aggravates hepatic injury in bile duct ligated mouse. Cellular and Molecular Gastroenterology and Hepatology, 2019.","DOI":"10.1016\/j.jcmgh.2019.12.008"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0710","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.surg.2010.07.046","article-title":"Partial bile duct ligation in mice: a novel model of acute cholestasis","volume":"149","author":"Heinrich","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.bcp.2020.114173_b0715","article-title":"Partial bile duct ligation in the mouse: a controlled model of localized obstructive cholestasis","volume":"133","author":"Yokota","year":"2018","journal-title":"JoVE (J. Visual. Exp.)"},{"issue":"48","key":"10.1016\/j.bcp.2020.114173_b0720","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1016\/j.vaccine.2013.07.023","article-title":"Prevention of cholestasis in the murine rotavirus-induced biliary atresia model using passive immunization and nonreplicating virus-like particles","volume":"31","author":"Hertel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.bcp.2020.114173_b0725","doi-asserted-by":"crossref","unstructured":"K. Lorent W. Gong K.A. Koo O. Waisbourd-Zinman S. Karjoo X. Zhao et al. Identification of a plant isoflavonoid that causes biliary atresia Sci Transl Med 7 286 2015 p. 286ra67.","DOI":"10.1126\/scitranslmed.aaa1652"},{"key":"10.1016\/j.bcp.2020.114173_b0730","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biochi.2019.07.027","article-title":"Improved hepatic MRP2\/ABCC2 transport activity in LPS-induced cholestasis by aquaporin-1 gene transfer","volume":"165","author":"Marrone","year":"2019","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0735","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.clinre.2018.07.010","article-title":"Systematic review of progressive familial intrahepatic cholestasis","volume":"43","author":"Baker","year":"2019","journal-title":"Clinics Res. Hepatol. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0740","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/MPG.0000000000002670","article-title":"NR1H4-related Progressive Familial Intrahepatic Cholestasis 5: Further Evidence for Rapidly Progressive Liver Failure","volume":"70","author":"Himes","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0745","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ng0398-219","article-title":"A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis","volume":"18","author":"Bull","year":"1998","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0750","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.21212","article-title":"Rudi de Waart, et al., Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport","volume":"44","author":"Paulusma","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0755","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks","year":"1998","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0760","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","article-title":"Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"37","key":"10.1016\/j.bcp.2020.114173_b0765","doi-asserted-by":"crossref","first-page":"12598","DOI":"10.1021\/bi050943e","article-title":"Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice","volume":"44","author":"Lam","year":"2005","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0770","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.08.017","article-title":"Metabolic preconditioning protects BSEP\/ABCB11(-\/-) mice against cholestatic liver injury","volume":"66","author":"Fuchs","year":"2017","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0775","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0780","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)-\/-mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro-and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0785","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1194\/jlr.M088070","article-title":"Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2\u2212\/\u2212 mice","volume":"60","author":"Wang","year":"2019","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0790","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3390\/cells9020281","article-title":"Glycochenodeoxycholate Promotes Liver Fibrosis in Mice with Hepatocellular Cholestasis","volume":"9","author":"Hohenester","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0795","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4254\/wjh.v11.i5.450","article-title":"Expanding etiology of progressive familial intrahepatic cholestasis","volume":"11","author":"Henkel","year":"2019","journal-title":"World Journal of Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0800","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI42846","article-title":"Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis","volume":"121","author":"Anakk","year":"2011","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0805","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1074\/jbc.M412752200","article-title":"The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter","volume":"280","author":"Dawson","year":"2005","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0810","first-page":"G1124","article-title":"Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST\u03b1-OST\u03b2 in cholestasis in humans and rodents. American Journal of Physiology-Gastrointestinal and Liver","volume":"290","author":"Boyer","year":"2006","journal-title":"Physiology"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0815","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/BJ20070716","article-title":"Heterodimerization, trafficking and membrane topology of the two proteins, Ost alpha and Ost beta, that constitute the organic solute and steroid transporter","volume":"407","author":"Li","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2020.114173_b0820","article-title":"OST\u03b1 deficiency: A disorder with cholestasis, liver fibrosis and congenital diarrhea","author":"Gao","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0825","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/hep.23265","article-title":"Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis","volume":"51","author":"Soroka","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.bcp.2020.114173_b0830","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0835","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/hep.29516","article-title":"Organic solute transporter-\u03b2 (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis","volume":"68","author":"Sultan","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0840","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41575-019-0156-4","article-title":"Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases","volume":"16","author":"Fabris","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bcp.2020.114173_b0845","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31228","article-title":"Intestinal microbiome-macrophage crosstalk contributes to cholestatic liver disease by promoting intestinal permeability","author":"Isaacs-Ten","year":"2020","journal-title":"Hepatology"},{"issue":"10139","key":"10.1016\/j.bcp.2020.114173_b0850","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0855","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.bcp.2020.114173_b0860","first-page":"1","article-title":"Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase\/histamine signaling","author":"Kennedy","year":"2020","journal-title":"Lab. Invest."},{"key":"10.1016\/j.bcp.2020.114173_b0865","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ebiom.2019.09.013","article-title":"Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2\u2212\/\u2212 mouse model of primary sclerosing cholangitis (PSC)","volume":"48","author":"Zhou","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2020.114173_b0870","doi-asserted-by":"crossref","DOI":"10.1016\/S0618-8278(19)30307-X","article-title":"Monoacylglycerol lipase inhibition protects from liver injury in mouse models of sclerosing cholangitis","author":"Tardelli","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2020.114173_b0875","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-319091","article-title":"TGF-\u03b22 silencing to target biliary-derived liver diseases","author":"Dropmann","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0880","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1194\/jlr.RA119000243","article-title":"A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice","volume":"61","author":"de Boer","year":"2020","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0885","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1194\/jlr.RA119000395","article-title":"Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition","volume":"61","author":"Honda","year":"2020","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bcp.2020.114173_b0890","doi-asserted-by":"crossref","unstructured":"V. Singh B.S. Yeoh B. Chassaing X. Xiao P. Saha R. Aguilera Olvera et al. Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer Cell 175 3 2018 679 694.e22.","DOI":"10.1016\/j.cell.2018.09.004"},{"key":"10.1016\/j.bcp.2020.114173_b0895","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced Th17 differentiation in patients with primary sclerosing cholangitis (PSC)","author":"Kunzmann","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.bcp.2020.114173_b0900","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1053\/j.gastro.2016.01.037","article-title":"Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease","volume":"150","author":"Anstee","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2020.114173_b0905","doi-asserted-by":"crossref","unstructured":"N. Chalasani X. Guo R. Loomba M.O. Goodarzi T. Haritunians S. Kwon et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease Gastroenterology 139 5 2010 pp. 1567\u20131576. e6.","DOI":"10.1053\/j.gastro.2010.07.057"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0910","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/hep.24333","article-title":"Genome-wide association studies in primary sclerosing cholangitis: still more questions than answers?","volume":"53","author":"Chapman","year":"2011","journal-title":"Hepatology (Baltimore, MD)"},{"key":"10.1016\/j.bcp.2020.114173_b0915","doi-asserted-by":"crossref","unstructured":"Gulamhusein, A.F., B.D. Juran, and K.N. Lazaridis. Genome-wide association studies in primary biliary cirrhosis. in Seminars in liver disease. 2015. Thieme Medical Publishers.","DOI":"10.1055\/s-0035-1567831"},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b0920","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2013.03.053","article-title":"The genetics of complex cholestatic disorders","volume":"144","author":"Hirschfield","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0925","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"Jiang","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2020.114173_b0930","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31229","article-title":"Genetic pathways in nonalcoholic fatty liver disease: Insights from systems biology","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0935","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0940","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jhep.2019.05.030","article-title":"Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis","volume":"71","author":"Glaser","year":"2019","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0945","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0950","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41467-018-03299-5","article-title":"Paracrine cellular senescence exacerbates biliary injury and impairs regeneration","volume":"9","author":"Ferreira-Gonzalez","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.bcp.2020.114173_b0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.02.015","article-title":"Biallelic mutations in DCDC2 cause neonatal sclerosing cholangitis in a Chinese family","author":"Lin","year":"2020","journal-title":"Clinics Res. Hepatol. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b0960","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41436-018-0288-x","article-title":"Identification of novel loci for pediatric cholestatic liver disease defined by KIF12, PPM1F, USP53, LSR, and WDR83OS pathogenic variants","volume":"21","author":"Maddirevula","year":"2019","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b0965","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jhep.2016.07.017","article-title":"Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis","volume":"65","author":"Grammatikopoulos","year":"2016","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b0970","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajhg.2014.12.002","article-title":"DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling","volume":"96","author":"Schueler","year":"2015","journal-title":"Am. J. Human Gene."},{"key":"10.1016\/j.bcp.2020.114173_b0975","doi-asserted-by":"crossref","unstructured":"\u00dcnl\u00fcsoy Aksu, A., S.K. Das, C. Nelson\u2010Williams, D. Jain, F. \u00d6zbay Ho\u015fnut, G. Evirgen \u015eahin, et al., Recessive Mutations in KIF12 Cause High Gamma\u2010Glutamyltransferase Cholestasis. Hepatology communications, 2019. 3(4): p. 471-477.","DOI":"10.1002\/hep4.1320"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b0980","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/hep.29029","article-title":"Knockout of the primary sclerosing cholangitis-risk gene Fut2 causes liver disease in mice","volume":"66","author":"Maroni","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b0985","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/gut.49.4.565","article-title":"Identification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression","volume":"49","author":"Shackel","year":"2001","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b0990","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhepr.2019.05.006","article-title":"Promoter hypermethylation of the AE2\/SLC4A2 gene in PBC","volume":"1","author":"Arenas","year":"2019","journal-title":"JHEP Reports"},{"issue":"30","key":"10.1016\/j.bcp.2020.114173_b0995","doi-asserted-by":"crossref","first-page":"28588","DOI":"10.18632\/oncotarget.5665","article-title":"CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a, b\u2212\/\u2212 mice favoring autoimmune cholangitis","volume":"6","author":"Concepcion","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b1000","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis","volume":"203","author":"Irie","year":"2006","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1005","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.173.4.2315","article-title":"Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain","volume":"173","author":"Koarada","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b1010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b1015","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-\u03b2 receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b1020","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor \u03b1\u2212\/\u2212 mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56181-9","article-title":"Genetic association of E26 transformation specific sequence 1 polymorphisms with the susceptibility of primary biliary cholangitis in China","volume":"9","author":"Xu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114173_b1030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102372","article-title":"Fine mapping of the MHC region identifies major independent variants associated with Han Chinese primary biliary cholangitis","volume":"107","author":"Wang","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bcp.2020.114173_b1035","article-title":"Identification of Marker Genes and Pathways in Patients with Primary Biliary Cholangitis","author":"Dong","year":"2019","journal-title":"J. Comput. Biol."},{"issue":"12","key":"10.1016\/j.bcp.2020.114173_b1040","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.4049\/jimmunol.157.12.5315","article-title":"Impaired survival and proliferation in IL-7 receptor-deficient peripheral T cells","volume":"157","author":"Maraskovsky","year":"1996","journal-title":"J. Immunol."},{"issue":"35","key":"10.1016\/j.bcp.2020.114173_b1045","doi-asserted-by":"crossref","first-page":"25184","DOI":"10.1074\/jbc.M603912200","article-title":"CCL5-CCR5-mediated Apoptosis in T cells requirement for glycosaminoglycan binding and CCL5 aggregation","volume":"281","author":"Murooka","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2020.114173_b1050","first-page":"321","article-title":"Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"Greverath","year":"2019","journal-title":"Hepatology Research"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b1055","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","article-title":"Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame","volume":"61","author":"Ibrahim","year":"2016","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1060","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0300060519833527","article-title":"Pathogenesis of and major animal models used for nonalcoholic fatty liver disease","volume":"47","author":"Jiang","year":"2019","journal-title":"J Int Med Res"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b1065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.bcp.2020.114173_b1070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/574832","article-title":"Nonalcoholic steatohepatitis: a search for factual animal models","author":"Sanches","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2020.114173_b1075","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14035","article-title":"Incretin combination therapy for the treatment of non-alcoholic steatohepatitis","author":"Kannt","year":"2020","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b1080","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b1085","first-page":"G825","article-title":"Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. American Journal of Physiology-Gastrointestinal and Liver","volume":"301","author":"Charlton","year":"2011","journal-title":"Physiology"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b1090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b1095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med Mol Morphol"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b1100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"Asgharpour","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b1105","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","author":"Larter","year":"2008","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1110","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1053\/j.gastro.2009.06.045","article-title":"c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice","volume":"137","author":"Kodama","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b1115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1120","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2020.114173_b1125","doi-asserted-by":"crossref","first-page":"G117","DOI":"10.1152\/ajpgi.00246.2015","article-title":"Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice","volume":"310","author":"Handa","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1130","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbrc.2006.02.032","article-title":"Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice","volume":"342","author":"Arsov","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2020.114173_b1135","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.bbadis.2018.04.024","article-title":"Animal models of NAFLD from the pathologist's point of view","volume":"1865","author":"Denk","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"10.1016\/j.bcp.2020.114173_b1140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.hepres.2006.07.009","article-title":"Exacerbation of dietary steatohepatitis and fibrosis in obese, diabetic KK-A(y) mice","volume":"36","author":"Okumura","year":"2006","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b1145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/excr.2001.5266","article-title":"Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice","volume":"268","author":"Cook","year":"2001","journal-title":"Exp Cell Res"},{"issue":"6","key":"10.1016\/j.bcp.2020.114173_b1150","first-page":"1175","article-title":"Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice","volume":"21","author":"Meyer","year":"2002","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2020.114173_b1155","doi-asserted-by":"crossref","unstructured":"M. Krawczyk R. Liebe F. Lammert Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond Gastroenterology 158 7 2020 1865 1880.e1.","DOI":"10.1053\/j.gastro.2020.01.053"},{"issue":"32","key":"10.1016\/j.bcp.2020.114173_b1160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016704","article-title":"Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease","volume":"98","author":"Karrar","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.bcp.2020.114173_b1165","doi-asserted-by":"crossref","unstructured":"Liu, J., J. Xing, B. Wang, C. Wei, R. Yang, Y. Zhu, et al., Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis. Medical science monitor: international medical journal of experimental and clinical research, 2019. 25: p. 1078.","DOI":"10.12659\/MSM.912737"},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b1170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014324","article-title":"Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis","volume":"98","author":"Dai","year":"2019","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.bcp.2020.114173_b1175","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215026","article-title":"An exploratory phenome wide association study linking asthma and liver disease genetic variants to electronic health records from the Estonian Biobank","volume":"14","author":"James","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bcp.2020.114173_b1185","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.bcp.2020.114173_b1190","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1053\/j.gastro.2020.01.049","article-title":"Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?","volume":"158","author":"Aron-Wisnewsky","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220304093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220304093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:19:47Z","timestamp":1757769587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220304093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":238,"alternative-id":["S0006295220304093"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114173","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114173"}}